Visual Abstract (IMAGE)

Providence Health & Services

Visual Abstract

Caption

Transplant recipients from SARS-CoV-2 NAT+ donors have 30-day graft and patient survival similar to NAT- donors. DTAC review finds zero transmissions after lower respiratory tract testing policy.

Credit

Jason Goldman, M.D.

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.